NO20074100L - Mikroimplantater for okulaer administrering - Google Patents

Mikroimplantater for okulaer administrering

Info

Publication number
NO20074100L
NO20074100L NO20074100A NO20074100A NO20074100L NO 20074100 L NO20074100 L NO 20074100L NO 20074100 A NO20074100 A NO 20074100A NO 20074100 A NO20074100 A NO 20074100A NO 20074100 L NO20074100 L NO 20074100L
Authority
NO
Norway
Prior art keywords
microplants
implants
ocular administration
methods
microns
Prior art date
Application number
NO20074100A
Other languages
English (en)
Other versions
NO339496B1 (no
Inventor
Thierry Nivaggioli
David A Weber
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of NO20074100L publication Critical patent/NO20074100L/no
Publication of NO339496B1 publication Critical patent/NO339496B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/0004—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof bioabsorbable
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)

Abstract

Det beskrives implantater og mikroimplantater som omfatter homogene blandinger av et virkestoff og en bionedbrytbar polymerer, som inkluderer mikroimplantater som har diametere på 483 ?m eller mindre og som kan avleveres til øyet ved bruk av selvforseglende metoder. Videre beskrives fremgangsmåter for fremstilling av implantatene og mikroimplantatene som fører til partier av høyt ensartede implantater og mikroimplantater innenfor meget snevre toleranseområder.
NO20074100A 2005-03-01 2007-08-08 Mikroimplantater for okulær administrering NO339496B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/070,158 US20060204548A1 (en) 2005-03-01 2005-03-01 Microimplants for ocular administration
PCT/US2006/006279 WO2006093758A1 (en) 2005-03-01 2006-02-22 Microimplants for ocular administration

Publications (2)

Publication Number Publication Date
NO20074100L true NO20074100L (no) 2007-11-23
NO339496B1 NO339496B1 (no) 2016-12-19

Family

ID=36579748

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20074100A NO339496B1 (no) 2005-03-01 2007-08-08 Mikroimplantater for okulær administrering

Country Status (17)

Country Link
US (1) US20060204548A1 (no)
EP (2) EP1863420B1 (no)
JP (2) JP2008531687A (no)
KR (1) KR101271362B1 (no)
CN (1) CN101188989B (no)
AU (1) AU2006218931B2 (no)
BR (1) BRPI0607483A2 (no)
CA (1) CA2598512C (no)
ES (1) ES2678401T3 (no)
IL (1) IL185250A0 (no)
MX (1) MX2007010305A (no)
NO (1) NO339496B1 (no)
NZ (2) NZ588831A (no)
RU (1) RU2357709C1 (no)
TR (1) TR201810174T4 (no)
WO (1) WO2006093758A1 (no)
ZA (1) ZA200706622B (no)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6726918B1 (en) 2000-07-05 2004-04-27 Oculex Pharmaceuticals, Inc. Methods for treating inflammation-mediated conditions of the eye
AU3649502A (en) 2000-11-29 2002-06-11 Oculex Pharm Inc Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor
US20050048099A1 (en) 2003-01-09 2005-03-03 Allergan, Inc. Ocular implant made by a double extrusion process
US20050244469A1 (en) 2004-04-30 2005-11-03 Allergan, Inc. Extended therapeutic effect ocular implant treatments
ES2432556T3 (es) 2004-08-04 2013-12-04 Evonik Corporation Métodos para fabricar dispositivos de suministro y sus dispositivos
AU2005314426A1 (en) * 2004-12-10 2006-06-15 Talima Therapeutics, Inc. Compositions and methods for treating conditions of the nail unit
US20060275230A1 (en) 2004-12-10 2006-12-07 Frank Kochinke Compositions and methods for treating conditions of the nail unit
US20070178138A1 (en) * 2006-02-01 2007-08-02 Allergan, Inc. Biodegradable non-opthalmic implants and related methods
JP5694664B2 (ja) * 2006-09-29 2015-04-01 サーモディクス，インコーポレイティド 生分解性眼用インプラント及び眼の病気を治療する方法
US8435544B2 (en) 2007-10-08 2013-05-07 Lux Biosciences, Inc. Ophthalmic compositions comprising calcineurin inhibitors or mTOR inhibitors
US8728528B2 (en) 2007-12-20 2014-05-20 Evonik Corporation Process for preparing microparticles having a low residual solvent volume
US8557273B2 (en) * 2008-04-18 2013-10-15 Medtronic, Inc. Medical devices and methods including polymers having biologically active agents therein
USRE48948E1 (en) 2008-04-18 2022-03-01 Warsaw Orthopedic, Inc. Clonidine compounds in a biodegradable polymer
US20100239632A1 (en) 2009-03-23 2010-09-23 Warsaw Orthopedic, Inc. Drug depots for treatment of pain and inflammation in sinus and nasal cavities or cardiac tissue
EP4108216A1 (en) 2009-06-03 2022-12-28 Forsight Vision5, Inc. Anterior segment drug delivery
ES2537385T3 (es) 2009-06-09 2015-06-08 Aurinia Pharmaceuticals Inc. Sistemas de suministro tópico para uso oftálmico
US8529492B2 (en) 2009-12-23 2013-09-10 Trascend Medical, Inc. Drug delivery devices and methods
US8939948B2 (en) * 2010-06-01 2015-01-27 Forsight Vision5, Inc. Ocular insert apparatus and methods
US8349005B2 (en) 2011-01-03 2013-01-08 Masatoshi Murata Method for burying implant to choroid
RU2494775C1 (ru) * 2012-06-21 2013-10-10 Федеральное государственное бюджетное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Министерства здравоохранения и социального развития Российской Федерации Способ лечения люэтической оптической нейропатии
WO2014004845A1 (en) * 2012-06-29 2014-01-03 Johnson & Johnson Vision Care, Inc. Method and ophthalmic device for galvanic healing of an eye
PT2911623T (pt) 2012-10-26 2019-11-21 Forsight Vision5 Inc Sistema oftálmico para libertação prolongada de fármaco no olho
JP2016514024A (ja) 2013-03-14 2016-05-19 ハラックス，インコーポレイテッド 爪部の感染症、疾患または障害の治療方法
RU2557925C1 (ru) * 2014-03-17 2015-07-27 Новиков Сергей Викторович Биодеградируемый многослойный имплант для введения лекарственных веществ в витреальную полость глаза
US20160296532A1 (en) 2015-04-13 2016-10-13 Forsight Vision5, Inc. Ocular Insert Composition of a Semi-Crystalline or Crystalline Pharmaceutically Active Agent
TWI799366B (zh) 2015-09-15 2023-04-21 美商建南德克公司 胱胺酸結骨架平臺
TWI748962B (zh) 2015-09-23 2021-12-11 美商建南德克公司 抗ｖｅｇｆ抗體之最佳化變異體
EP3515404B1 (en) * 2016-10-28 2020-03-18 Spinethera Pharmaceutical compositions and uses thereof
US20190224275A1 (en) 2017-05-12 2019-07-25 Aurinia Pharmaceuticals Inc. Protocol for treatment of lupus nephritis
CN107595765A (zh) * 2017-09-22 2018-01-19 沈阳兴齐眼药股份有限公司 一种眼用缓释药物递送系统及其制备方法
WO2023107478A1 (en) * 2021-12-06 2023-06-15 Ocular Therapeutix, Inc. Extruded ocular inserts or implants and methods thereof
US11883561B1 (en) * 2022-10-21 2024-01-30 Reselute, Inc. Drug eluting implants and methods for producing the same

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4144317A (en) * 1975-05-30 1979-03-13 Alza Corporation Device consisting of copolymer having acetoxy groups for delivering drugs
US4346709A (en) * 1980-11-10 1982-08-31 Alza Corporation Drug delivery devices comprising erodible polymer and erosion rate modifier
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
JPS58126435U (ja) * 1982-02-19 1983-08-27 オリンパス光学工業株式会社 Ｔｔｌオ−トストロボ用絞り制御回路
US4668506A (en) * 1985-08-16 1987-05-26 Bausch & Lomb Incorporated Sustained-release formulation containing and amino acid polymer
US4959217A (en) * 1986-05-22 1990-09-25 Syntex (U.S.A.) Inc. Delayed/sustained release of macromolecules
US4853224A (en) * 1987-12-22 1989-08-01 Visionex Biodegradable ocular implants
US4997652A (en) * 1987-12-22 1991-03-05 Visionex Biodegradable ocular implants
US5164188A (en) * 1989-11-22 1992-11-17 Visionex, Inc. Biodegradable ocular implants
US5178635A (en) * 1992-05-04 1993-01-12 Allergan, Inc. Method for determining amount of medication in an implantable device
US5443505A (en) * 1993-11-15 1995-08-22 Oculex Pharmaceuticals, Inc. Biocompatible ocular implants
US5466233A (en) * 1994-04-25 1995-11-14 Escalon Ophthalmics, Inc. Tack for intraocular drug delivery and method for inserting and removing same
US6855331B2 (en) * 1994-05-16 2005-02-15 The United States Of America As Represented By The Secretary Of The Army Sustained release hydrophobic bioactive PLGA microspheres
US6369116B1 (en) * 1995-06-02 2002-04-09 Oculex Pharmaceuticals, Inc. Composition and method for treating glaucoma
US5869079A (en) * 1995-06-02 1999-02-09 Oculex Pharmaceuticals, Inc. Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
US20020111603A1 (en) * 1996-12-02 2002-08-15 Societe De Conseils De Recherches Et D'application Device for local administration of solid or semi-solid formulations and delayed-release formulations for proposal parental administration and preparation process
US6331313B1 (en) * 1999-10-22 2001-12-18 Oculex Pharmaceticals, Inc. Controlled-release biocompatible ocular drug delivery implant devices and methods
US6726918B1 (en) * 2000-07-05 2004-04-27 Oculex Pharmaceuticals, Inc. Methods for treating inflammation-mediated conditions of the eye
AU3649502A (en) * 2000-11-29 2002-06-11 Oculex Pharm Inc Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor
AU2003205278B2 (en) * 2002-01-18 2008-08-07 Psivida Us Inc. Polymeric gel system for the controlled delivery of codrugs
US6899717B2 (en) * 2002-09-18 2005-05-31 Allergan, Inc. Methods and apparatus for delivery of ocular implants
US20040137059A1 (en) * 2003-01-09 2004-07-15 Thierry Nivaggioli Biodegradable ocular implant
US20050048099A1 (en) * 2003-01-09 2005-03-03 Allergan, Inc. Ocular implant made by a double extrusion process

Also Published As

Publication number Publication date
EP2364680A1 (en) 2011-09-14
CA2598512C (en) 2018-08-14
TR201810174T4 (tr) 2018-08-27
CN101188989A (zh) 2008-05-28
US20060204548A1 (en) 2006-09-14
RU2357709C1 (ru) 2009-06-10
JP2008531687A (ja) 2008-08-14
IL185250A0 (en) 2008-02-09
ES2678401T3 (es) 2018-08-10
WO2006093758A1 (en) 2006-09-08
AU2006218931A1 (en) 2006-09-08
NO339496B1 (no) 2016-12-19
EP1863420B1 (en) 2018-04-18
BRPI0607483A2 (pt) 2009-09-08
KR101271362B1 (ko) 2013-06-10
NZ588831A (en) 2012-05-25
AU2006218931B2 (en) 2011-07-14
JP2013067644A (ja) 2013-04-18
NZ560397A (en) 2010-11-26
CN101188989B (zh) 2010-06-23
ZA200706622B (en) 2008-09-25
RU2007132699A (ru) 2009-04-10
CA2598512A1 (en) 2006-09-08
EP1863420A1 (en) 2007-12-12
KR20070116030A (ko) 2007-12-06
MX2007010305A (es) 2007-09-27

Similar Documents

Publication Publication Date Title
NO20074100L (no) Mikroimplantater for okulaer administrering
AU2018338608A1 (en) Methods, compositions, and implantable elements comprising active cells
EP2322219A3 (en) Use of IL-23 and IL-17 antagonists to treat autoimmune ocular inflammatory disease
WO2006132647A3 (en) Antimicrobial copolymers and uses thereof
BR0214992A (pt) Artigo microfibrilado hidrofìlico, e, método para preparar o mesmo
BRPI0510568A (pt) copolìmero, processo para preparação do mesmo, partìcula biodegradável, uso da mesma, processo para preparação de um sistema de liberação, composição para perfumar, e, produto perfumado
WO2007030266A3 (en) Nitric oxide-releasing polymers derived from modified polyimines
MA28334A1 (fr) Compositions pharmaceutiques antivirales
BRPI0506983A (pt) composições para terapia localizada dos olhos, compreendendo preferencialmente acetonida de triancinolona e ácido hialurÈnico
EP2397148A3 (en) Compositions and methods for the treatment of ophthalmic disease
ATE554725T1 (de) Chirurgische artikel zur behandlung von beckenerkrankungen
TW200637547A (en) Compounds and compositions as protein kinase inhibitors
MX356111B (es) Composiciones farmaceuticas disuasorias de abuso, de liberacion inmediata.
WO2008109347A3 (en) Methods for ex vivo administration of drugs to grafts using polymeric nanoparticles
WO2004039248A3 (en) Repairing or replacing tissues or organs
MX2017000041A (es) Formulaciones de liberacion inmediata disuasivas de abuso que comprenden polisacaridos no celulosicos.
NO20050366L (no) Depotformuleringer med kort varighet
BR112012027590A2 (pt) conjugado de fator viii de coagulação sanguínea
TR201908487T4 (tr) Oftalmolojik bileşimler ve kullanımları.
EP4286013A3 (en) Lrrc33 inhibitors and use thereof
BR112014006608A2 (pt) formulações com base em dispersões sólidas
WO2008070356A3 (en) Block biodegradable copolymers for medical devices
WO2006021001A3 (en) Amphiphilic polynorbornene derivatives and methods of using the same
BRPI0411752A (pt) implantes subcutáneos apresentando liberação inicial limitada do princìpio ativo e liberação ampliada subseqüente linearmente variável do mesmo
WO2020222139A9 (en) Formulations and methods for drug instillation into the bladder and treatment of bladder ailments